Focused on reducing the morbidity, mortality, and burden associated with venous thromboembolism (VTE), experts in this series describe the clinical presentation of VTE, its proper management (including special populations, such as those with cancer), and appropriate dosing of current treatment options. Listen and learn as clinicians relate practical applications of evidence-based guidelines for initial and extended VTE treatment, and secondary prevention. This activity is supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance.